ArticleOncology letters2023

CLPTM1L expression predicts recurrence of patients with intermediate‑ and high‑risk stage IB‑IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy.

Yuichiro Awazu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.